期刊:Biomaterials Science [The Royal Society of Chemistry] 日期:2020-01-01卷期号:8 (11): 3116-3129被引量:11
标识
DOI:10.1039/d0bm00003e
摘要
The advantages of PCM@Lip/IT NPs include mitochondrial-targeting, on-demand drug release, and prodrug activation by hypoxia with guidance/monitoring by PA and FL imaging.